SYNLAB : ESG data book 2023 | ENGLISH

Published: 2024-07-15 10:30:07 ET SYAB.DE

ESG DATA BOOK 2023

SYNLAB GROUP

Inhaltsverzeichnis

Content

Introduction_________________________________________________________________________________________ 3

ABOUT SYNLAB _____________________________________________________________________________________ 3

ESG DATA BOOK ____________________________________________________________________________________ 3

Non-financial targets overview _________________________________________________________________________ 4

OWN WORKFORCE __________________________________________________________________________________ 5

DATA PRIVACY ______________________________________________________________________________________ 7

GHG EMISSIONS_____________________________________________________________________________________ 8

WASTE _____________________________________________________________________________________________ 8

CYBERSECURITY ____________________________________________________________________________________ 9

COMMUNITY IMPACT _________________________________________________________________________________ 9

RESEARCH AND INNOVATION _________________________________________________________________________ 9

Introduction

ABOUT SYNLAB

SYNLAB Group ("the Group" or "SYNLAB"), with headquarters in Munich, Germany, is the leader in medical diagnostic services and specialty testing in Europe. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practicing doctors, hospitals and clinics, governments, and corporations. Providing a high level of service within the industry, SYNLAB is a partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers. SYNLAB operates in 33 countries across four continents and holds leading positions in most markets.

ESG DATA BOOK

This ESG Data Book contains ESG metrics of the SYNLAB Group to complement our 2023 Separate Non-Financial Group Report published within the Group Annual Report 2023. The data in this report covers the whole consolidation scope under SYNLAB AG and refers to the 2023 financial year (1 January 2023 to 31 December 2023). 2022 data, referring to the 2022 financial year (1 January 2022 to 31 December 2022) are also included for reference for selected indicators. SYNLAB uses the control principle defined by the International Financial Reporting Standards (IFRS) when determining the scope of reporting for the Group, unless otherwise stated. Non-financial data governance at SYNLAB follows financial data governance closely and has multiple layers of checks and approvals.

Non-financial targets overview

CARE-SOCIAL

2023

2022

Change Progress

Certify/accredit competence and quality management systems (QMS) of over 80% of our laboratories according to ISO 9001 or ISO 15189 or the appropriate local quality standard by 2025.

By 2026, achieve overall 30% female representation within the Key Strategic Successors Pipeline for CEO positions for any country representing at least 5% of total Group revenue.

Achieve female representation of 20% in first line management (Executive Committee) below the Management Board by 2026.

Achieve female representation of 45% in second line management below the Management Board by 2026.

Improve SYNLAB Dialogue employee engagement scores year after year until 2025.

Ensure participation of 100% of SYNLAB leaders (all leadership levels) in our ACCE development programme by 2026.

Between 2022 and 2030, increase average hours of role- related training per full time employee, by 10% year-on-year.

Loss time accident frequency rate (LTAFR) year-on-year reduction up to 2025.

72.9%

25.0%

10.0%

28.8%

4% against 2022 scores

3.3%

14.5 hours

8.8 lost time accidents per 1,000 FTEs

72.2%

50.0%

10.0%

26.2%

-5% against 2021 scores

<1.0%

12.7 hours

13.6 lost time accidents per 1,000 FTEs

0.7%

-25.0%

2.6%

>2.3%

14%

-35%

GREEN - ENVIRONMENT

Reduce scope 1 and 2 CO2e emissions intensity1 year after

11.9 Tonnes CO2e per

year and offset remaining unavoidable Group-wide emissions

million euros revenue

by 2027.

Certify 20% of Group laboratories according to ISO 14001 or

20.7%

equivalent by 2025, with a focus on central labs.

9.9 Tonnes CO2e per

20%

million euros revenue

20.2%

0.5%

CITIZENSHIP

Continue to maintain and grow our diagnostic services, year- on-year, in line with evolving demand for testing to address public health priorities. SYNLAB has defined the following indicator diseases for this target: HIV/AIDS, Tuberculosis, and antimicrobial resistance.

Train 95% of all employees on data privacy by 2025.

Achieve an aggregated grade A on SecurityScorecard by 2025.

Extend SecurityScorecard to the Cloud platforms by 2025.

Establish a Supplier Code of Conduct by 2025 for any new suppliers that represent more than 1% of the overall Group procurement spend.

Complete environmental and human rights due diligence assessment for more than 50% of reagent supplier spend by 2023.

Testing can be provided inall segments within SYNLAB network for the indicator diseases.

74.1%

Extension to cloud

applications started3.

In 2023, there were no new suppliers that met the criteria. Going beyond the target, SYNLAB started discussions with existing top suppliers on the topic. One of the top suppliers acknowledged SYNLAB Supplier Code of Conduct.

ESG due diligence was assessment was conducted for 63% of reagent supplier spend.

Testing can be provided in all segments within SYNLAB network for the indicator diseases.

60.0%

Not extended to the Cloud platforms.

SYNLAB Supplier Code of Conduct was developed and published online.

ESG due diligence questionnaire was developed.

14.1%

Target on track.

Target achieved.

ESG data

OWN WORKFORCE

Employee data

PECENTAGE OF EMPLOYEES BY GENDER AND NUMBER OF TOTAL EMPLOYEES (%)

Male

Female

Diverse/non-binary

Not reported

Total Employees (HC)

FTEs

2023

26%

74%

27047

23538

PERCENTAGE OF EMPLOYEES BY CONTRACT TYPE, BROKEN

Not

Total

DOWN BY GENDER (%)

Male

Female

Other*

reported

Employee

Percentage of employees

Percentage of permanent employees

Percentage of temporary employees

Others

74%

64%0%

9%0%

1%0%

100%

0% 85%

0% 13%

0%2%

*Gender as specified by the employees themselves.

PERCENTAGE OF EMPLOYEES BY CONTRACT TYPE, BROKEN

Not

Total

DOWN BY GENDER (%)

Male

Female

Other*

reported

Employee

Percentage of full-time employees

19%

Percentage of part-time employees

Others

51%

20%

70%

24%

*Gender as specified by the employees themselves.

PERCENTAGE OF EMPLOYEES BY CONTRACT TYPE, BROKEN

North &

Total

DOWN BY REGION (%)

France Germany

East

South Employee

Percentage of employees

18%

Percentage of permanent employees

14%

Percentage of temporary employees

Others

17%

15%

33%

27%

32%

29%

100%

85%

13%

PERCENTAGE OF EMPLOYEES BY CONTRACT TYPE, BROKEN

North &

Total

DOWN BY REGION (%)

France Germany

East

South Employee

Percentage of full-time employees

13%

Percentage of part-time employees

Others

24%

25%

71%

24%

Diversity

PERCENTAGE OF EMPLOYEE BY JOB LEVEL, BROKEN DOWN

Not

Total

BY GENDER (%)

Male

Female

Other*

reported

Employee

L1 - Supervisory Board

L2 - Management Board & Executive Committee

L3 - C-level(country-level)

L4 - Management

L5 - Team Leader

L6 - Team Members

58%

92%

52%

42%

48%

53%

67%

76%

<1%

92%

*Gender as specified by the employees themselves.

PERCENTAGE OF EMPLOYEES BY AGE GROUP (%)

2023

Employees - <30

23%

Employees - 30-50

49%

Employees - >50

28%

Employee engagement

SYNLAB DIALOGUE

Unit

2023

2022

Participation rate changes

67.0

70.0

Employee engagement score

+4% against

-5% against

Relative %

2022 scores

2021 scores

Training and skills development

TRAINING HOURS

2023

2022

Change

Average training hours per FTE

14.5

Average training hours per HC

12.6

12.714%

11.114%

Health and safety

HEALTH AND SAFETY4

Unit

2023

2022

Change

Fatalities

Work-related high consequence injuries and ill health (excl. Fatalities)

Number of recordable work-related accident

Loss time accident frequency rate (LTAFR)

325

8.8

4-75%

13.6-35%

In 2023, SYNLAB lost an employee due to a tragic car accident that took place while the employee was transporting samples. The reported fatality number refers to this case. Furthermore, one high consequence injury was reported, which occurred while using a microtome. Health and Safety in the SYNLAB workplace is of paramount importance. We are constantly seeking to minimise and remove any harmful risks in the workplace. At the group level, we set a lost-time accident frequency rate (LTAFR) target of a year-on-year reduction up to 2025.

Incidents, complaints, and severe human rights impact

INCIDENTS

2023

2022

Change

Number of severe human rights incidents

DATA PRIVACY

DATA PRIVACY TRAINING (%)

2023

2022

Change

Completion rate of privacy training of all employees

74.1%60.0%14.1%

4 Includes other workers working on the company site.

GHG EMISSIONS5

In FY 2023, SYNLAB conducted its first global Scope 3 emissions inventory to understand the amount and nature of our Scope 3 emissions. Scope 3 emissions include indirect emissions (other than those reported as Scope 1 or 2) that occur in our upstream and downstream value chain. As a provider of medical diagnostic services, our Scope 3 GHG emissions primarily occur in the upstream value chain. Our emissions boundary exercise identified the Scope 3 categories "Purchased goods & services", "Capital goods" and "Upstream transport & distribution" as material and Scope 3 categories 1-6 are included in the disclosure.

No carbon credits were purchased in 2023.

Unit

2023

2022

Change

Scope 1 GHG emissions

Gross Scope 1 emissions

Tonnes CO2e

Percentage of Scope 1 GHG emissions from regulated

emission trading schemes

19929 209256-5%

000%

Scope 2 GHG emissions

Gross location-based Scope 2 GHG emissions

Gross market-based Scope 2 GHG emissions

Significant Scope 3 GHG emissions

Total Gross indirect (Scope 3) GHG emissions

1 Purchased goods and services

2 Capital goods

3 Fuel and energy-related activities (not included in Scope1 or Scope 2)

4 Upstream transportation and distribution

5 Waste generated in operations

6 Business traveling

Total GHG emissions

Total GHG emissions (location-based)

Total GHG emissions (market-based)

Tonnes CO2e

Not

27241

reported

11527

113076

410433

352356

20486

1940

22469

11182

2000

457604

441889

WASTE

WASTE VOLUME

Unit

2023

2022

Change

Volume of hazardous waste disposed

Tonnes

5451 7704 -29%

CYBERSECURITY

CYBERSECURITY RATING

2023

2022

Aggregated Grade on SecurityScorecard

COMMUNITY IMPACT

Unit

2023

Local community investments

Euros [€]

848245

Employee volunteers

# Employees

1331

Income tax paid

Million Euros [€]

62.5

RESEARCH AND INNOVATION

2023

Number of scientific research publications

319

7 See footnote 2, page 4.

SYNLAB AG

Moosacher Straße 88

80809 Munich / Germany

ESG contact: [email protected]

Disclaimer

Synlab AG published this content on 15 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 July 2024 14:29:05 UTC.